Nautilus Biotechnology
High-throughput, low-cost platform for analyzing and quantifying the human proteome
2
Funding Rounds
$152.0m
Money raised
Overview
High-throughput, low-cost platform for analyzing and quantifying the human proteome
-
Website:
- Social accounts:
| Name | Phone | Social networks | |
|---|---|---|---|
| Su*** Pa*** |
|
- | - |
| Pa*** Ma | - | - |
| Name | Phone | Social networks | |
|---|---|---|---|
| Su*** Pa*** |
|
- | - |
| Pa*** Ma | - | - | |
| Dr* Vi*** S. Pa*** | - | - | |
| Me Ep | - | - | |
| Ka*** Ak** | - | - | |
| Ma** Po**** | - | - | |
| Mi Al**** | - | - | - |
| Ma** Mc* | - | - | twitter facebook |
| Fa**** Na*** | - | - |
Funding series
Funding Series Analysis
The company Nautilus Biotechnology has raised a total of $76m in funding over 2 rounds.
Key Insights:
- Nautilus Biotechnology Series B round, May 2020: $76m
- Nautilus Biotechnology Series B round May 2020: $76m
Nautilus Biotechnology Series B round, May 2020
$76m
Nautilus Biotechnology Series B round May 2020
$76m
Industries
Nautilus Biotechnology is active in the following industries: